Antimicrobial properties of the mushroom Agaricus blazei – integrative review

Revista Brasileira de Farmacognosia

Volumn 26, Issue 6, 2016, Pages 780-786

  Lima, Cristiane U J O ^a   Gris, Eliana F ^a   Karnikowski, Margô G O ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Agaricus blazei; Antibiotic; Antimicrobial; Antimicrobial agents; Infection

Indexed keywords

ACETIC ACID ETHYL ESTER; AGARICUS BLAZEI EXTRACT; ALCOHOL; DICHLOROMETHANE; HEXANE; WATER;

AGARICUS BLAZEI; ANTIMICROBIAL ACTIVITY; GRAM POSITIVE BACTERIUM; HYDRODISTILLATION; NONHUMAN; PERITONITIS; REVIEW; SUPERCRITICAL FLUID EXTRACTION;

EID: 85006251099     PISSN: None     EISSN: 1981528X     Source Type: Journal    
DOI: 10.1016/j.bjp.2016.05.013     Document Type: Short Survey

References (101)

1. Abella, J., Fahy, A., Duran, R., Cagnon, C., 2015. Integron diversity in bacterialcommunities of freshwater sediments at different contamination levels. FEMSMicrobiol. Ecol. 91, http://dx.doi.org/10.1093/femsec/fiv140.
2. Alves, M. J., Ferreira, I. C. F. R., Dias, J., Teixeira, V., Martins, A., Pintado, M. A., 2012. Review on antimicrobial activity of mushroom (Basidiomycetes) extract sandisolated compounds. Planta Med. 78, 1707-1718
3. Alves, M. J., Ferreira, I. C. F. R., Froufe, H. J. C., Abreu, R. M. V., Martins, A., Pintado, M., 2013. Antimicrobial activity of phenolic compounds identified in wild mush-rooms, SAR analysis and docking studies. J. Appl. Microbiol. 115, 346-357
4. Arenz, S., Wilson, D. N., 2016. Blast from the past: reassessing forgotten transla-tion inhibitors, antibiotic selectivity, and resistance mechanisms to aid drugdevelopment. Mol. Cell 61, 3-14
5. Bernardshaw, S., Hetland, G., Grinde, B., Johnson, E., 2006. An extract of the mush-room Agaricus blazei Murill protects against lethal septicemia in a mouse modelfor fecal periotonitis. Shock 24, 319-320
6. Bernardshaw, S., Johnson, E., Hetland, G., 2005. An extract of the mushroom Agar-icus blazei Murill administered orally protects against systemic Streptococcuspneumoniae infection in mice. Scand. J. Immunol. 62, 393-398
7. Bertéli, M. B., Umeo, S. H., Bertéli, A., do Valle, J. S., Linde, G. A., Colauto, N. B., 2014. Mycelial antineoplastic activity of Agaricus blazei. World J. Microbiol. Biotechnol. 30, 2307-2313
8. Bork, A. M. T., 2005. Enfermagem baseada em evidências. In: Soares, B. G. O. (Ed.), Prática de Enfermagem Baseada em Evidências. Guanabara Koogan, Rio deJaneiro, pp. 3-13
9. Breidenstein, E. B. M., de la Fuente-Núñez, C., Hancock, R. E. W., 2011. Pseudomonasaeruginosa: all roads lead to resistance. Trends Microbiol. 8, 419-426
10. Carneiro, A. A., Ferreira, I. C., Barros, L., da Silva, R., Gomes, E., Santos-Buelga, C., 2013. Chemical composition and antioxidant activity of dried powder formulations ofAgaricus blazeiand Lentinus edodes. Food Chem. 138, 2168-2173
11. Carvajal, A. E. S. S., Koehnlein, E. A., Soares, A. A., Eler, G. J., Nakashima, A. T. A., Bracht, A., Peralta, R. M., 2012. Bioactives of fruiting bodies and submerged culture myceliaof Agaricus brasiliensis (A. blazei) and their antioxidant properties. LWT-FoodSci. Technol. 46, 493-499
12. Chan, Y., Chang, T., Chan, C. H., Yeh, Y., Chen, C., Shieh, B., Li, C., 2007. Immunomod-ulatory effects of Agaricus blazei Murill in BalbcByJ mice. J. Microbiol. Immunol. Infect. 40, 201-208
13. Chan, G. C., Chan, W. K., Sze, D. M., 2009. The effects of beta-glucan on humanimmune and cancer cells. J. Hematol. Oncol. 10, http://dx.doi.org/10.1186/1756-8722-2-25
14. Cordeiro, V. R., Bach, E., 2006. Peroxidase and Poliphenoloxidase Differenciated FungiAgaricus and Ganoderma, Colombo., pp. 115 (Embrapa Florestas. Documento, 183).
15. Dai, Y. C., Zhou, L. W., Cui, B. K., Chen, Y. Q., Decock, C., 2010. Current advances in Phelli-nus sensu lato: medicinal species, functions, metabolites and mechanisms. Appl. Microbiol. Biotechnol. 87, 1587-1593
16. Dalonso, N., Goldman, G. H., Gern, R. M., 2015. β-(1→3), (1→6)-Glucans: medici-nal activities, characterization, biosynthesis and new horizons. Appl. Microbiol. Biotechnol. 99, 78937-79906
17. Davey, P. G., Marwick, C., 2008. Appropriate vs. inappropriate antimicrobial therapy. Clin. Microbiol. Infect. 14, 15-21
18. Ellertsen, L. K., Hetland, G., Johnson, E., Grinde, B., 2006. Effect of a medicinal extractfrom Agaricus blazei Murill on gene expression in a human monocyte cell lineas examined by microarrays and immuno assays. Int. Immunopharmacol. 6, 133-143
19. Endo, M., Beppu, H., Akiyama, H., Wakamatsu, K., Ito, S., Kawamoto, Y., Shimpo, T., Koike, T., Matsui, T., 2010. Agaritine purified from Agaricus blazei Murrillexerts anti-tumor activity against leukemic cells. Biochim. Biophys. Acta 1800, 669-673
20. Firenzuoli, F., Gori, L., Lombardo, G., 2007. The medicinal mushroom Agaricus blazeiMurrill: review of literature and pharmaco-toxicological problems. Evid. Based. Complement. Altern. Med. 5, 3-15
21. Fistarol, G. O., Coutinho, F. H., Moreira, A. P., Venas, T., Cánovas, A., de Paula Jr., S. E., deMoura, R. L., Valentin, J. L., Tenenbaum, D. R., Paranhos, R., do Valle, R. A., Vicente, A. C., Amado Filho, G. M., Pereira, R. C., Kruger, R., Rezende, C. E., Thompson, C. C., Salomon, P. S., Thompson, F. L., 2015. Environmental andsanitary conditions of Guanabara Bay, Rio de Janeiro. Front. Microbiol., 6, http://dx.doi.org/10.3389/fmicb.2015. 01232.
22. Fortes, R. C., Novaes, M. R. C. G., 2006. Efeitos da suplementaç ão dietética com cogume-los Agaricales e outros fungos medicinais na terapia contra o câncer. Rev. Bras. Cancerol. 52, 363-371
23. Gao, L., Sun, Y., Chen, C., Xi, Y., Wang, J., Wang, Z., 2007. Primary mechanism ofapoptosis induction in a leukemia cell line by fraction FA-2-b-β prepared fromthe mushroom ABM. Braz. J. Med. Biol. Res. 40 (11), 1545-1555
24. Gilbert, D. N., Guidos, R. J., Boucher, H. W., Talbot, G. H., Spellberg, B., Edwards J. E Jr, Scheld, W. M., Bradley, J. S., Bartlett, J. G., 2010. Infectious Diseases Societyof America. The 10 ×’20 initiative: pursuing a global commitment to develop 10new antibacterial drugs by 2020. Clin. Infect. Dis. 50, 1080-1083
25. Godshall, C. J., Scott, M. J., Burch, P. T., Peyton, J. C., Cheadle, W. G., 2003. Natural killercells participate in bacterial clearance during septic peritonitis through interac-tions with macrophages. Shock 19, 144-149
26. Gonzaga, M. L., Bezerra, D. P., Alves, A. P., de Alencar, N. M., Mesquita, R. O., Lima, M. W., Soares, S. A., Pessoa, C., de Moraes, M. O., Costa-Lotufo, L. V., 2009. In vivogrowth-inhibition of Sarcoma 180 by an β-(1→4)-glucan-_-(1→6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill. J. Nat. Med. 63, 32-40
27. Hakime-Silva, R. A., Vellosa, J. C., Khalil, N. M., Khalil, O. A., Brunetti, I. L., Oliveira, O. M., 2013. Chemical, enzymatic and cellular antioxidant activity studies of Agaricusblazei Murrill. An. Acad. Bras. Cienc. 85, 1073-1081
28. Hetland, G., Lovik, M., Wiker, H. G., 1998. Protective effect of beta-glucan againstMycobacterium bovis, BCG infection in BALB/c mice. Scand. J. Immunol. 47, 548-553
29. Hetland, G., Ohno, N., Aaberge, I. S., Lovik, M., 2000. Protective effect of β-glucanagainst systemic Streptococcus pneumoniae infection in mice. FEMS Immunol. Med. Microbiol. 27, 111-116
30. Hetland, G., Sandven, P., 2002. β-1, 3-Glucan reduces growth of Mycobacterium bovisin macrophage cultures. FEMS Immunol. Med. Microbiol. 33, 41-45
31. Hetland, G., Johnson, E., Lyberg, T., Bernardshaw, S., Tryggestad, A. M. A., Grinde, B., 2008. Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and Cancer. Scand. J. Immunol. 68, 363-370
32. Hetland, G., Johnson, E., Eide, D. M., Grinde, B., Samuelsen, A. B. C., Wiker, H. G., 2013. Antimicrobial effects of β-glucans and pectin and of the Agaricusblazei based mushroom extract, AndoSanTM. Examples of mouse models forpneumococcal-, fecal bacterial-, and mycobacterial infections. In: MicrobialPathogens and Strategies for Combating Them: Science, Technology and Edu-cation., pp. 889-898
33. Hong, G., Gu, W., 2007. Quantitative determination of ergosterol in Agaricus brasilien-sis by triple-wavelength spectrophotometry. Chin. J. Anal. Chem. 35, 586-588
34. Hsu, C. H., Hwang, K. C., Chiang, Y. H., Chou, P., 2008. The mushroom Agaricus blazeiMurill extract normalizes liver function in patients with chronic hepatitis B. J. Altern. Complement. Med. 14, 299-301
35. Hu, S. H., Cheung, P. C., Hung, R. P., Chen, Y. K., Wng, J. C., Chang, S. J., 2015. Antitu-mor and immunomodulating activities of exopolysaccharide produced by bigcup culinary-medicinal mushroom clitocybe maxima (higher basidiomycetes)in liquid submerged culture. Int. J. Med. Mushrooms 17, 891-901
36. Huang, C. B., Alimova, Y., Myers, T. M., Ebersole, J. L., 2011. Short and medium-chainfatty acids exhibit antimicrobial activity for oral microorganisms. Arch. Oral Biol. 56, 650-654
37. Huttner, A., Harbarth Carlet, S., Cosgrove, J. S., Goossens, H., Holmes, A., Jarlier, V., Voss, A., Pillet, D., 2013. Antimicrobial resistance: a global view from the 2013World Healthcare-Associated Infections Forum. Antimicrob. Resist. Infect. Con-trol 18, http://dx.doi.org/10.1186/2047-2994-2-31
38. Ishii, P. L., Prado, C. K., Mauro, M., Carreira, C. M., Mantovani, M. S., Ribeiro, L. R., Dich, J. B., Oliveira, R. J., 2011. Evaluation of Agaricus blazei in vivo is antigenotoxic, anticarcinogenic, immunomodulatory and phagocytic activities. Regul. Toxicol. Pharmacol. 59, 412-422
39. Jia, S., Li, F., Liu, Y., Ren, H., Gong, G., Wang, Y., Wu, S., 2013. Effects of extractionmethods on the antioxidant activities of polysaccharides from Agaricus blazeiMurrill. Int. J. Biol. Macromol. 62, 66-69
40. Johnson, E., Forland, D. T., Saetre, L., Bernardshaw, S. V., Lyberg, T., Hetland, G., 2009. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill onrelease of cytokines, chemokines and leukocyte growth factors in human bloodex vivo and in vivo. Scand. J. Immunol. 69, 242-250
41. Jumes, F. M., Lugarini, D., Pereira, A. L., de Oliveira, A., Christoff, A. O., Linde, G. A., do Valle, J. S., Colauto, N. B., Acco, A., 2010. Effects of Agaricus brasiliensismushroom in Walker-256 tumor-bearing rats. Can. J. Physiol. Pharmacol. 88, 21-27
42. Kaneno, R., Fontanari, L. M., Santos, S. A., Di Stasi, L. C., Rodrigues Filho, E., Eira, A. F., 2004. Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on theNK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearingmice. Food Chem. Toxicol. 42, 909-916
43. Kasai, H., He, L. M., Kawamura, M., Yang, P. T., Deng, X. W., Munkanta, M., Yamashita, A., Terunuma, H., Hirama, M., Horiuchi, I., Natori, T., Koga, T., Amano, Y., Yam-aguchi, N., Ito, M., 2004. IL-12 production induced by Agaricus blazei fraction H(ABH) involves toll-like receptor (TLR). Evid. Based. Complement. Altern. Med. 1, 259-267
44. Kawamura, M., Kasai, H., He, L., Deng, X., Yamashita, A., Terunuma, H., Horiuchi, I., Tanabe, F., Ito, M., 2005. Antithetical effects of hemicellulase-treated Agar-icus blazei on the maturation of murine bone-marrow-derived dendritic cells. Immunology 114, 397-409
45. Kelly, R., Zoubiane, G., Walsh, D., Ward, R., Grossens, H., 2016. Public funding forresearch on antibacterial resistance in the JPIAMR countries, the EuropeanCommission, and related European Union agencies: a systematic observationalanalysis. Lancet Infect. Dis. 6, 431-440
46. Khudaibergenova, M. S., 2015. Antimicrobial use at a multi-disciplinary hospital. Int. J. Risk Saf. Med. 27 (Suppl 1), S13-S14.
47. Kisich, K. O., Higgins, M., Diamond, G., Heifets, L., 2002. Tumor necrosis factor alphastimulates killing of Mycobacterium tuberculosis by human neutrophils. Infect. Immun. 70, 4591-4599
48. Koneman, E. W., Allen, S. E., Janda, W. M., Schreckenberger, P. D., Winn, W. C., 1999. Diagnóstico Microbiológico Texto y Atlas Color, 5th ed. Buenos Ayres, Panamer-icana.
49. Lambert, M. L., Suetens, C., Savey, A., Palomar, M., Hiesmayr, M., Morales, I., Agodi, A., Frank, U., Mertens, K., Shumacher, M., Wolkewitz, M., 2010. Clinical outcomesof health-care-associated infections and antimicrobial resistance in patientsadmitted to European intensive-care units: a cohort study. Lancet Infect. Dis. 11, 30-38
50. Laxminarayan, R., Duse, A., Wattal, C., Zaid, A. K., Wertheim, H. F., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I., Goossens, H., Greko, C., So, A. D., Bigdeli, M., Tomson, G., Woodhouse, W., Ombaka, E., Peralta, A. Q., Qamar, F. N., Mir, F., Kar-iuki, S., Bhutta, Z. A., Coates, A., Bergstrom, R., Wright, G. D., Brown, E. D., Cars, O., 2013. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 13, 1057-1098
51. Lee, J. Y., Kim, Y. S., Shin, D. H., 2002. Antimicrobial synergistic effect of linolenic acidand monoglyceride against Bacillus cereus and Staphylococcus aureus. J. Agric. Food Chem. 50, 2193-2199
52. Licking, E., 1999. Getting a grip on bacterial slime. Bus. Week, 98-100
53. Lim, L., Lee, C., Chang, E., 2012. Optimization of solid state culture conditions forthe production of adenosine, cordycepin, and D-mannitol in fruiting bodies ofmedicinal caterpillar fungus Cordyceps militaris (L.:Fr.) Link (Ascomycetes). Int. J. Med. Mushrooms 14, 181-187
54. Lima, C. U. J. O., Karnikowski, M. G. O., Carolino, V., Morita, M. C., Chiarello, M. D., 2012. Agaricus blazei Murill and inflammatory mediators in elderly women: random-ized clinical trial. Scand. J. Immunol. 75, 336-341
55. Lister, P. D., Wolter, D. J., Hanson, N. D., 2009. Antibacterial-resistant Pseudomonasaeruginosa: clinical impact and complex regulation of chromosomally encodedresistance mechanisms. Clin. Microbiol. Rev. 22, 582-610
56. Lull, C., Wichers, H. J., Savelkoul, H. F. J., 2005. Antiinflammatory and immunomodu-lating properties of fungal metabolites. Mediators Inflamm. 2, 63-80
57. Lund, R. G., Del Pino, F. A. B., Serpa, R., Nascimento, J. S., Silva, V. M., Ribeiro, G. A., Ros-alen, P. L., 2009. Agaricus brasiliensis against mutans streptococci. Pharm. Biol. 47, 910-915
58. Machado, M. P., Filho, E. R., Terezan, A. P., Ribeiro, L. R., Mantovani, M. S., 2007. Cyto-toxicity, genotoxicity and antimutagenicity of hexane extracts of Agaricus blazeidetermined in vitro by the comet assay and CHO/HGPRT gene mutation assay. Toxicol. Mech. Methods 17, 147-152
59. Mah, T. F. C., O’Toole, G. A., 2001. Mechanisms of biofilm resistance to antimicrobialagents. Trends Microbiol. 9, 34-39
60. Mazzutti, S., Ferreira, S. R. S., Riehl, C. A. S., Smania A Jr, Smania, F. A., Martínez, J., 2012. Supercritical fluid extraction of Agaricus brasiliensis: antioxidant and antimicro-bial activities. J. Supercrit. Fluids 70, 48-56
61. Meyer, E., Gastmeier, P., Deja, M., Schwab, F., 2013. Antibiotic consumptionand resistance: data from Europe and Germany. Int. J. Med. Microbiol. 303, 388-395
62. Mertz, D., Brooks, A., Irfan, N., Sung, M., 2015. Antimicrobial stewardship in theintensive care setting-a review and critical appraisal of the literature. SwissMed. Wkly. 145, 14220.
63. Montoya, S., Sanches, O. J., Levin, L., 2013. Polysaccharide production by submergedand solid-state cultures from several medicinal higher Basidiomycetes. Int. J. Med. Mushrooms 15, 71-79
64. Morgan, D. J., Okeke, I. N., Laxminarayan, R., Perencevich, E. N., Weisenberg, S., 2011. Non-prescription antimicrobial use worldwide: a systematic review. LancetInfect. Dis. 11, 692-701
65. Mourão, F., Umeo, H. S., Takemura, S. O., Linde, A. G., Colauto, B. N., 2011. Antioxidantactivity of Agaricus brasiliensis basidiocarps on different maturation phases. Braz. J. Microbiol. 42, 197-202
66. Odonkor, S. T., Addo, K. K., 2011. Bacteria resistance to antibiotics: recent trends andchallenges. Int. J. Biol. Med. Res. 2, 1204-1210
67. Oliveira, A. L., Eler, G. J., Bracht, A., Peralta, R. M., 2010. Purinergic effects of a hydroal-coholic Agaricus brasiliensis (A. blazei) extract on liver functions. J. Agric. FoodChem. 58, 7202-7210
68. Ohno, N., Furukawa, M., Miura, N. N., Adachi, Y., Motoi, M., Yadomae, T., 2001. Anti-tumor beta glucan from the cultured fruit body of Agaricus blazei. Biol. Pharm. Bull. 24, 820-828
69. Osaki, Y., Kato, T., Yamamoto, K., Okubo, J., Miyazaki, T., 1994. Antimutagenic andbactericidal substances in the fruit body of a Basidiomycete Agaricus blazei, Jun-17. Yakugaku Zasshi 114, 342-350
70. Padilla, M. M., Avila, A. A., Sousa, P. J., 2009. Anti-inflammatory activity of aqueousand alkaline extracts from mushrooms (Agaricus blazei Murill). J. Med. Food 12, 359-364
71. Piddock, L. J., 2012. The crisis of no new antibiotics-what is the way forward? LancetInfect. Dis. 12, 249-253
72. Riollet, C., Pascal, R., Bernard, P., 2000. Differential induction of complement frag-ment C5a and inflammatory cytokines during intramammary infections withEscherichia coli and Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 7, 161-167
73. Sanhueza, C. J., Nieto, K. S., Valenzuela, B. A., 2002. Acido linoleico conjugado: un acidograso con isomeria trans potencialmente beneficioso. Rev. Chil. Nutr. 29, 98-105
74. Schweizer, H. P., 2003. Efflux as a mechanism of resistance to antimicrobials in Pseu-domonas aeruginosa and related bacteria: unanswered questions. Genet. Mol. Res. 2, 48-62
75. Shimizu, S., Kitada, H., Yokota, H., Yamakawa, J., Murayama, T., Sugiyama, K., Izumi, H., Yamaguchi, N., 2002. Activation of the alternative complement pathway byAgaricus blazei Murill. Phytomedicine 9, 536-545
76. Shin, M. S., Lee, S., Lee, K. Y., Lee, H. G., 2005. Structural and biological characterizationof aminated-derivatized oat beta-glucan. J. Agric. Food Chem. 53, 5554-5558
77. Shu, C. H., Lin, K. J., 2011. Effects of aeration rate on the production of ergosterol andblazeispirol A by Agaricus blazei in batch cultures. J. Taiwan Inst. Chem. Eng. 42, 212-216
78. Silva, A. C., Oliveira, M. C., Del-Re, P. V., Jorge, N., 2009. Use of the mushroom extractsnatural antioxidant in soybean oil. Sci. Agrotechnol. 33, 1103-1108
79. Smiderle, F. R., Ruthes, A. C., van Arkel, J., Chanput, W., Iacomini, M., Wichers, H. J., Van Griensven, L. J., 2011. Polysaccharides from Agaricus bisporus and Agaricusbrasiliensis show similarities in their structures and their immunomodula-tory effects on human monocytic THP-1 cells. BMC Complement. Altern. Med., http://dx.doi.org/10.1186/1472-6882-11-58
80. Smyth, M. J., Hayakawa, Y., Takeda, K., Yagita, H., 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2, 850-861
81. Soares, A. A., Souza, C. G. M., Daniel, F. M., Ferrari, G. P., Costa, S. M. G., Peralta, R. M., 2009. Antioxidant activity and phenolic content of Agaricus brasiliensis (Agaricus blazeiMurrill) in two stages of maturity. Food Chem. 112, 775-781
82. Soković, M., Ćirić, A., Glamočlija, J., Nikolić, M., van Griensven L. J. L. D., 2014. Agaricusblazei hot water extract shows anti quorum sensing activity in the nosocomialhuman pathogen Pseudomonas aeruginosa. Molecules 19, 4189-4199
83. Sorimachi, K., Akimoto, K., Ikehara, Y., Inafuku, K., Okubo Yamazaki, A. S., 2001. Secre-tion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with Agaricusblazei Murill fractions in vitro. Cell Struct. Funct. 26, 103-108
84. Stojkovic, D., Reis, F. S., Barros, L., Glamoclija, J., Ciric, A., van Griensven, L. J., Sokovic, M., Ferreira, I. C., 2013. Nutrients and non-nutrients composition and bioactivityof wild and cultivated Coprinus comatus (O. F. Müll.) Pers. Food Chem. Toxicol. 59, 289-296
85. Stojkovic, D., Reis, F. S., Barros, L., Glamoclija, J., Ciric, A., Barros, L., van Griensven, L. J., Sokovic, M., Ferreira, I. C., 2014. Cultivated strains of Agaricus bisporus and A. brasiliensis: chemical characterization and evaluation of antioxidant and antimi-crobial properties for the final healthy product-natural preservatives in yoghurt. Food Funct. 5, 1602-1612
86. Stokes, H. W., Gillings, M. R., 2011. Gene flow, mobile genetic elements and therecruitment of antibiotic resistance genes into Gram-negative pathogens. FEMSMicrobiol. Rev. 3, 790-819
87. Su, C. H., Lai, M. N., Lin, C. C., Ng, C. C., 2016. Comparative characterization ofphysicochemical properties and bioactivities of polysaccharides from selectedmedicinal mushrooms. Appl. Microbiol. Biotechnol. 177, 1-9
88. Ta, C. A. K., Arnason, J. T., 2016. Mini review of phytochemicals and plant taxa withactivity as microbial biofilm and quorum sensing inhibitors. Molecules 21, http://dx.doi.org/10.3390/molecules21010029
89. Takaku, T., Kimura, Y., Okuda, H., 2001. Isolation of an antitumor compound fromAgaricus blazei Murill and its mechanism of action. J. Nutr. 13, 1409-1413
90. Takimoto, H., Wakita, D., Kawaguchi, K., Kumazawa, Y., 2004. Potentaion of cytotoxicactivity in naïve and tumor-bearing mice by oral administration of hot-waterextracts from Agaricus blazei fruiting bodies. Biol. Pharm. Bull. 27 (Suppl. 3), S404-S406.
91. Thabit, A. K., Crandon, J. L., Nicolau, D. P., 2015. Antimicrobial resistance: impact onclinical and economic outcomes and the need for new antimicrobials. ExpertOpin. Pharmacother. 16, 159-177
92. Torjesen, I., 2013. Antimicrobial resistance presents an apocalyptic threat simi-lar to that of climate change, CMO warns. BMJ 346, http://dx.doi.org/10.1136/bmj.f1597.
93. Tryggestad, A. M., Espevik, T., Ryan, L., Hetland, G., 2013. The medicinal mushroomAgaricus blazei Murill promotes NF-κB activation via stimulation of TLR2 andinhibits its activation via TLR4. J. Pharm. Biomed. Sci. 29, 753-761
94. Tsai, S. Y., Tsai, H. L., Mau, J. L., 2007. Antioxidant properties of Agaricusblazei. Agrocybe cylindracea and Boletus edulis. Food Sci. Technol. 40, 1392-1402
95. Uyanoglu, M., Canbek, M., van Griensven, L. J., Yamac, M., Senturk, H., Kartkaya, K., Oglakci, A., Turgak, O., Kanbak, G., 2014. Effects of polysaccharide from fruitingbodies of Agaricus bisporus, Agaricus brasiliensis, and Phellinus linteus on alcoholicliver injury. Int. J. Food Sci. Nutr. 65, 482-488
96. WHO, 2011. Antimicrobial Resistance: No Action Today, No Cure Tomorrow. WHOWorld Health Day, World Health Organization, Genebra.
97. Wu, S., Li, F., Jia, S., Ren, H., Gong, G., Wang, Y., Ly, Z., Liu, Y., 2014. Drying effectson the antioxidant properties of polysaccharides obtained from Agaricus blazeiMurrill. Carbohydr. Polym. 15, 414-417
98. Yamanaka, D., Motoi, M., Ishibashi, K., Miura, N. N., Adachi, Y., Ohno, N., 2012. Effect of Agaricus brasiliensis-derived cold water extract on Toll-like receptor 2-dependent cytokine production in vitro. Immunopharmacol. Immunotoxicol. 34, 561-570
99. Yuminamochi, E., Koike, T., Takeda, K., Okumura, I. H. K., 2007. Interleukin-12-andinterferon-γ-mediated natural killer cell activation by Agaricus blazei Murill. Immunology 121, 197-206
100. Zhuqiu, Y., Zhang, Y., 2001. Study of antibacterial effects of Agaricus blazei. J. FoodSci. 22, 84-87
101. Zou, X., 2006. Fed-batch fermentation for hyperproduction of polysaccharide andergosterol by medicinal mushroom Agaricus brasiliensis. Process Biochem. 41, 970-974